Higher levels of immune proteins are present in the blood both before and after an epileptic seizure. Researchers say the biomarkers can be identified via a simple blood test.
Activating TREM2 on microglia in the brains of those with Alzheimer's could help slow down the progression of the neurodegenerative disease.
A new study reveals it is not only possible to determine Alzheimer's risks before symptoms appear, but it is also possible to determine who will deteriorate within the next few years.
Trigger finger, a condition in which the fingers get locked into a bent position and become difficult to straighten, is more common in those with diabetes than in the general population. High blood sugar levels increase the risk of developing trigger finger, researchers say.
Converting skin cell samples into neurons helps researchers gain a better understanding of the mechanisms of Huntington's disease.
Brain folds that form during fetal development may have an impact on the age at which symptoms of frontotemporal dementia occur.
Like cognitive deficits, psychiatric symptoms such as depression, apathy, and anxiety associated with Alzheimer's disease appear to be a direct consequence of underlying brain changes as a result of increased amyloid-beta accumulation.
Researchers examine the neuroscience behind why we make certain decisions when faced with multiple choices.
The answer to what makes the human brain unique may lie in junk DNA.
Amyloid-beta accumulates in nerve cells and spreads, from cell to cell, via nerve fibers. This process occurs prior to the formation of amyloid plaques in the brain.
A new algorithm that uses data from memory tests and blood samples is able to accurately predict an individual's risk for developing Alzheimer's disease.
Researchers have identified four distinct subtypes of Alzheimer's disease. The findings could lead to more individualized treatments for those with the neurodegenerative disorder.
